Multiple Choice

A company that sells a patented, highly specialized medication for a chronic condition is considering a permanent 30% price increase. The medication has no direct competitors. Two executives are debating the strategy:

  • Executive A argues: "Let's proceed. In the first six months, our revenue will soar. Patients depend on this medication daily and have no other immediate choice, so the quantity demanded will barely drop."
  • Executive B argues: "I'm cautious. This price hike could acc

0

1

Updated 2025-07-17

Contributors are:

Who are from:

Tags

Social Science

Empirical Science

Science

Economy

CORE Econ

Economics

Introduction to Microeconomics Course

The Economy 2.0 Microeconomics @ CORE Econ

Related